CRIS Competitors & Alternatives
Compare Curis Inc with similar stocks in the same industry
Biotechnology
CRIS
Main Stock$4.65
Tradestie Score
54
Market Cap
$20.87M
Revenue Growth
-0.7%
Analyst Upside
+5921.5%
Top Competitors
230 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
FBRX
Forte Biosciences, Inc. Common Stock
|
$43.20
|
$180.53M | - | 56 | Compare |
|
AVTX
Avalo Therapeutics, Inc. Common Stock
|
$18.42
|
$170.45M | - | 61 | Compare |
|
ACHV
Achieve Life Sciences, Inc.
|
$6.31
|
$158.43M | - | 57 | Compare |
|
NVCT
Nuvectis Pharma, Inc. Common Stock
|
$18.29
|
$154.27M | - | 51 | Compare |
|
CLYM
Climb Bio, Inc. Common Stock
|
$13.24
|
$133.50M | - | 59 | Compare |
|
AGEN
Agenus Inc.
|
$5.08
|
$124.27M | 1.6 | 60 | Compare |
|
STTK
Shattuck Labs, Inc. Common Stock
|
$6.29
|
$114.01M | - | 60 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$27.80
|
$110.20M | - | 62 | Compare |
|
RLMD
Relmada Therapeutics, Inc. Common Stock
|
$6.21
|
$71.69M | - | 54 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$10.68
|
$67.94M | - | 62 | Compare |
More CRIS Analysis
Data updated: Jul 14, 2026 | Industry: Biotechnology (SIC 2836)
230 stocks in this industry